Skip to content

VR to Improve CINV, Sleep and Pain Among Children With Cancer in HK

The Use of a Virtual Reality Device (HypnoVR®) to Improve Chemotherapy-induced Nausea and Vomiting, Sleep Quality and Pain Among Children With Cancer in Hong Kong

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04853303
Enrollment
180
Registered
2021-04-21
Start date
2021-09-01
Completion date
2025-06-30
Last updated
2021-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Child, Nausea, Neoplasms, Pain, Sleep Hygiene, Vomiting

Brief summary

Chemotherapy-induced nausea and vomiting, sleep quality and pain are the common symptoms experienced by children with cancer. These symptoms significantly devastate the children's quality of life. Hypnosis is found to be effective in managing chemotherapy-induced nausea and vomiting, sleep quality and pain in children with cancer. In addition, virtual reality is shown to promote the effectiveness of hypnosis in managing these symptoms. However, no study so far has examine it effectiveness in Hong Kong Chinese children with cancer. This study aims to investigate the effectiveness in the use a virtual reality device to improve chemotherapy-induced nausea and vomiting, sleep quality and pain among children with cancer in Hong Kong.

Detailed description

This study is a randomized controlled trial. We recruit 180 children with cancer who are aged 9 to 18 and Chinese speaking and allocate them into experimental and control group. The experimental group will receive a 15-minute hypnosis using virtual reality when they are experiencing chemotherapy-induced nausea and vomiting, sleep quality or pain. The control group will receive no intervention.

Interventions

DEVICEHypnosis VR

Children will be required to wear a VR gadget for hypnosis when they are experiencing chemotherapy-induced nausea and vomiting, sleep quality or pain. The duration is 15 minutes.

Sponsors

The Hong Kong Polytechnic University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
9 Years to 18 Years
Healthy volunteers
Yes

Inclusion criteria

* Aged 9 to 18 * Can read Chinese and speak Cantonese * diagnosed with cancer

Exclusion criteria

* with mental disabilities or cognitive dysfunction as identified in the medical record

Design outcomes

Primary

MeasureTime frameDescription
Pittsburgh Sleep Quality Index (PSQI) at the 6-month follow-upat the 6-month follow-upChildren will be required to fill in the Pittsburgh Sleep Quality Index (PSQI) at the 6-month follow-up. The score ranges from 0 to 21. Higher scores represent to poorer sleep quality.
The Pediatric Nausea Assessment Tool (PeNAT) at the 6-month follow-upat the 6-month follow-upChildren will be required o fill in the Chinese version of the Pediatric Nausea Assessment Tool (PeNAT) at 6-month follow-up. The score ranges from 1 to 4. Higher scores represent a more severe nausea.
Visual Analogue Pain Scale (VAS) at the 6-month follow-upat the 6-month follow-upChildren will be required to fill in the Visual Analogue Pain Scale (VAS) at 6-month follow-up. The score ranges from 0 to 10. Higher scores represent a higher level of pain.

Secondary

MeasureTime frameDescription
Pittsburgh Sleep Quality Index (PSQI) at baselineat baselineChildren will be required to fill in the Pittsburgh Sleep Quality Index (PSQI) at baseline. The score ranges from 0 to 21. Higher scores represent to poorer sleep quality.
Pittsburgh Sleep Quality Index (PSQI) at 1-month follow-upat 1-month follow-upChildren will be required to fill in the Pittsburgh Sleep Quality Index (PSQI) at 1-month follow-up. The score ranges from 0 to 21. Higher scores represent to poorer sleep quality.
Pittsburgh Sleep Quality Index (PSQI) at 3-month follow-upat 3-month follow-upChildren will be required to fill in the Pittsburgh Sleep Quality Index (PSQI) at 3-month follow-up. The score ranges from 0 to 21. Higher scores represent to poorer sleep quality.
The Pediatric Nausea Assessment Tool (PeNAT) at baselineat baselineChildren will be required to fill in the Chinese version of the Pediatric Nausea Assessment Tool (PeNAT) at baseline. The score ranges from 1 to 4. Higher scores represent a more severe nausea.
Visual Analogue Pain Scale (VAS) at 1-month follow-upat 1-month follow-upChildren will be required to fill in the Visual Analogue Pain Scale (VAS) at 1-month follow-up. The score ranges from 0 to 10. Higher scores represent a higher level of pain.
Visual Analogue Pain Scale (VAS) at 3-month follow-upat 3-month follow-upChildren will be required to fill in the Visual Analogue Pain Scale (VAS) at 3-month follow-up. The score ranges from 0 to 10. Higher scores represent a higher level of pain.
Visual Analogue Pain Scale (VAS) at baselineat baselineChildren will be required to fill in the Visual Analogue Pain Scale (VAS) at baseline. The score ranges from 0 to 10. Higher scores represent a higher level of pain.
The Pediatric Nausea Assessment Tool (PeNAT) at 1-month follow-upat 1-month follow-upChildren will be required to fill in the Chinese version of the Pediatric Nausea Assessment Tool (PeNAT) at 1-month follow-up.The score ranges from 1 to 4. Higher scores represent a more severe nausea.
The Pediatric Nausea Assessment Tool (PeNAT) at 3-month follow-upat 3-month follow-upChildren will be required to fill in the Chinese version of the Pediatric Nausea Assessment Tool (PeNAT) at 3-month follow-up. The score ranges from 1 to 4. Higher scores represent a more severe nausea.

Contacts

Primary ContactEva Ho, PhD
kyanho@polyu.edu.hk27666417
Backup ContactKatherine Lam, PhD
kwkatlam@polyu.edu.hk27666420

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026